Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity
- 1 February 2001
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 7 (1) , 19-22
- https://doi.org/10.1177/135245850100700104
Abstract
A growing body of evidence implicates excessive generation of nitric oxide (NO) within the central nervous system (CNS) in multiple sclerosis (MS). The aim of our study is to analyse nitrite and nitrate as end products of NO in the cerebrospinal fluid (CSF) from MS patients and correlate the concentrations with clinical characteristics of the disease. CSF nitrite and nitrate concentrations were measured after reduction of nitrate, by Griess reaction, in 105 MS patients, 27 patients with non-inflammatory neurological disorders (NIND) and 13 individuals without neurological disorder (Co). Mean CSF nitrite and nitrate concentrations were significantly higher in patients with MS and NIND compared with the Co patients (9.44 and 8.68, respectively, versus 6.85 μM; P=0.0001 and P=0.031, respectively). There was no significant correlation between CSF nitrite and nitrate concentrations and activity, phase, severity and duration of MS. Our data are in agreement with the results of previous studies which have demonstrated raised concentrations of CSF NO metabolites in MS patients, providing further evidence for NO involvement in MS. The lack of correlation between NO metabolites and disease activity speaks in favour of the possible dual role of NO, as both immunoregulatory and proinflammatory molecule, in the pathogenesis of MS.Keywords
This publication has 29 references indexed in Scilit:
- Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis ratsClinical and Experimental Immunology, 1999
- Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: Sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthaseJournal of the Neurological Sciences, 1999
- Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator?Immunology Today, 1998
- Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosisMultiple Sclerosis Journal, 1998
- Inducible nitric oxide synthase: what difference does it make?Journal of Clinical Investigation, 1997
- Measurement of Upregulation of Inducible Nitric Oxide Synthase in the Experimental Autoimmune Encephalomyelitis Model Using a Positron Emitting RadiopharmaceuticalNitric Oxide, 1997
- Evidence for increased nitric oxide production in multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.Journal of Clinical Investigation, 1994
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983